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INTRODUCTION 
Magnetic resonance (MR) phase-velocity mapping 
(PVM) is a technique that has been widely used clini-
cally to measure blood flow. The technique provides tra-
ditional anatomical information using MR imaging and 
blood velocity information in any spatial direction using 
the phase-velocity encoding technique . This technique is 
based on the fact that, by using the proper magnetic-field 
gradients, the velocity can be encoded within the phase 
of the detected signal. This phase-velocity encoding fol-
lows a li near equation: 
(I ) 
where 4> is the phase of the received signal (rad), "y is the 
gyromagnetic ratio (HzIT), II is the velocity (assumed 
constant) (m/s), and M, is the first moment of the gra-
dient wave ronn (T s2/m) at the echo ti me (TE): 
(2) 
where C(t) is the magnetic-field gradient (TIm). Two 
acquisitions are perromled, one in which the velocity is 
compensated and one in which the velocity is encoded. 
By subtracting the two images pixel by pixel with re-
spect to the phase or the signal, a phasc image can be 
constructed which contains velocity inrormation jor each 
pixel according to Eq. (I). 
Modern PVM was invented in 1982 by Moran.24 
There have been many in vitro and clinical studies evalu-
ating the potential and reliability or PVM for now char-
acterization or quantification . In vitro, the accuracy 
of PVM was found 10 be consistently high, with errors 
of less than 10%.4- 6.8.12.21 In vivo studies showed a 
good correlation between PVM and conventional veloci-
metric (Doppler ultrasound) and Rowmetric 
techniques.4•13•21.22.26.27 The clinical application or r VM 
to quantiry or visualize blood Row in the heart, through 
heart valves, and in the great vessels has been 
extensive.3.1·16- 18.22.26.JO With the development or more 
powerrul hardware and software, flow quantification in 
Tube No. 
1 
2 
3 
4 
Tube ID (cm) 
0.56 
1.47 
2.02 
2.62 
TABLE 1. Flow conditions. 
Steady flow rate 
(ml/s) 
1.7, 5, 8.3, 16.7 
6.7, 16.7, 66.7, 116.7 
10, 25, 33.3, 83.3, 166.7 
16.7, 50, 116.7, 200 
Pulsatile flow volume 
(ml/cycle) 
6 
20 and 30 
40 and 60 
70 and 90 
smaller vessels, such as the coronary arteries, has be-
come possible. 
Conventional PVM involves a gradient-echo sequence 
with bipolar velocity-encoding gradients applied in the 
desired direction for velocity measurement. The acquisi-
tion can be prospectively or retrospectively referenced to 
the ECG signal of the subject in order to acquire a 
number of velocity measurements (time phases) through-
out the cardiac cycle. Only one line of k-space (fre-
quency domain) is acquired for each phase per heartbeat. 
As a result, the acquisition of a single velocity compo-
nent requires several minutes (typically, 3–5 min, de-
pending on functional and imaging parameters). Consid-
ering that blood flow measurement is usually only part of 
a complete cardiac MR examination and that new veloci-
metric diagnostic approaches have started to involve 
multislice and multidirectional velocity acquisitions,8,31,32 
this single k-space line (nonsegmented) acquisition tech-
nique becomes less practical clinically. 
With the development of rapid imaging sequences, it 
has become possible to implement PVM much faster. 
The two most prominent sequences for ultrafast PVM are 
multishot echo-planar imaging (EPI) and turbo gradient 
echo (TGE). Instead of acquiring a single k-space line 
during each time phase per cardiac cycle, multiple lines 
or segments of k-space lines are acquired during each 
time phase. Consequently, the acquisition can be per-
formed in seconds, instead of minutes. 
The similarity between segmented k-space TGE and 
multishot EPI is that both acquire multiple lines or seg-
ments of k-space per phase, in contrast to the conven-
tional, nonseqmented, gradient-echo sequence that ac-
quires only a single line. The difference is that in TGE 
acquisition of each line of the segment requires a sepa-
rate excitation, whereas in EPI all lines of the segment 
are acquired after a single excitation. Because of the 
absence of multiple excitation pulses, EPI is generally 
faster. However, the longer effective echo time of EPI 
combined with the specific gradient function of EPI 
cause flow-related signal voids, especially in relatively 
disturbed flow fields, and other image artifacts. TGE has 
shown better flow behavior and is, therefore, more prom-
ising for reliable ultrafast flow quantification with rela-
tively disturbed flow and significant vessel motion (e.g., 
coronary arteries).9,10,14,20,25 In addition, previous in vitro 
and clinical studies2,10,11,14,19,20,23,25,28,29 evaluating both 
EPI and TGE techniques for PVM have indicated that 
TGE is generally superior in terms of temporal and 
(sub-millimeter28) in-plane spatial resolution. 
The aim of this study was to evaluate the segmented 
k-space TGE sequence in quantifying flow from through-
plane velocity measurements. An in vitro study was per-
formed under a variety of flow conditions and imaging 
parameters, followed by preliminary clinical measure-
ments. 
METHODS 
In vitro and in vivo studies were performed in a 1.5 T 
Siemens Sonata whole-body MRI scanner (Siemens 
Medical Systems, Erlangen, Germany) with a maximum 
gradient strength of 40 mT/m. First, in vitro PVM mea-
surements were performed with steady and pulsatile wa-
ter flow through four straight PVC tubes with inside 
diameters of 5.6 mm (tube No. 1), 14.7 mm (tube No. 2), 
20.2 mm (tube No. 3), and 26.2 mm (tube No. 4). The 
tubes were placed in a water container to insure detec-
tion of adequate MR signal. Then, in vivo PVM mea-
surements were performed in the ascending aorta of two 
human subjects, one with an ascending aortic aneurysm, 
and one with ischemic heart disease. 
Experimental Conditions 
Steady flow studies were first performed using a range 
of flow rates (1.7–200 ml/s, Table 1). The Reynolds 
number (Re) range studied was 400–10,500. The true 
flow rate was known via precalibrated rotameters. Then, 
pulsatile flow studies (see the flow loop in Fig. 1) were 
FIGURE 1. Pulsatile flow loop. 
FIGURE 2. True flow wave form generated by the piston 
pump as measured by the MR-compatible ultrasonic flow 
probe. 
conducted using a computer-controlled piston pump (Su-
perPump, SPS 3891, Vivitro Systems Inc., Victoria, Brit-
ish Columbia, Canada) to provide flow pulsatility. A 
hardware/software system (Vivigen Waveform Generator 
VG8991, Vivitro Systems Inc.) was used to program and 
download a sinusoidal flow wave form from a PC to the 
piston pump. The piston stroke volumes studied were 
6–90 ml/cycle (Table 1) under a rate of 60 cycles/min. 
The true flow wave form (Fig. 2) was measured with a 
precalibrated, MR-compatible (brass), transit-time ultra-
sonic flow probe (20N in-line, Transonic Systems, Inc., 
Ithaca, NY). The flow data from the probe was acquired 
by a single channel flow meter (T-106, Transonic Sys-
tems, Inc.). The flow wave form was recorded on a PC 
by digitizing the analog signal from the flow meter with 
an analog-to-digital board (PCI-MIO-16E-4, National In-
struments Inc., Austin, TX), using the LabVIEW soft-
ware (Version 5.0, National Instruments, Inc.). Integra-
tion of the flow curve during the cycle provided the true 
flow volume. 
In Vitro Imaging Procedure 
The test section (water-filled container with sub-
merged straight tubes) was connected to the flow loop, 
and the entire system was inserted into the bore of the 
scanner with the test section placed at the isocenter. 
Initial true fast imaging with steady-state precession 
(FISP) scout images in all three spatial orientations 
(axial, coronal, and sagittal) showed the location of the 
tubes. An imaging slice was then placed axially, perpen-
dicular to the long axis of the tube under study. Three 
PVM acquisitions of the through-plane velocity were 
performed for each flow condition, using the following 
three sequences: (a) conventional nonsegmented gradient 
echo with one k-space line per time phase and cycle; (b) 
segmented TGE with five k-space lines per time phase 
and cycle; and (c) segmented TGE with nine lines per 
time phase and cycle. In all sequences, the flow-sensitive 
and the flow-compensated data (which were subtracted to 
provide the phase data) were acquired in an interleaved 
manner in the same cycle. The flip angle was 30°. The 
slice thickness (ST) was 5 or 3 mm. The field of view 
(FOV) was 160X160 mm2 (for tube No. 1), 200X200 
mm2 (for tube Nos. 1, 2, and 3), and 300X300 mm2 (for 
tube Nos. 2, 3, and 4). The acquisition matrix size was 
192X256 for sequence (a), 140X256 for sequence (b), 
and 144X256 for sequence (c). The nominal voxel size 
varied between 0.6X0.8X3 and 0.6X1.6X5 mm3 for 
sequence (a), between 0.6X1.1X3 and 0.6X2.1X5 mm3 
for sequence (b), and between 0.6X1.1X3 and 0.6 
X2.1X5 mm3 for sequence (c). Therefore, for a recon-
structed matrix of 256X256, the voxel size (after inter-
polation) varied from 0.6X0.6X3 to 1.2X1.2X5 mm3 
in all sequences. The shortest possible TE (2.3–3.5 ms) 
was used. In sequence (a), the repetition time (TR) was 
30 ms. In sequences (b) and (c), the time to acquire data 
for any one ky line (actual TR) varied between 5.2 and 
5.6 ms, depending on the imaging parameters, such as 
ST and FOV. The echo was acquired asymmetrically 
within the data acquisition period. The peak of the echo 
occurred at data-point 82 of 256 and the missing data 
points were zero filled. The velocity encoding value 
(above which aliasing would take place) was 20–150 
cm/s, depending on the magnitude of the flow. 
In the case of pulsatile flow, a transistor–transistor 
logic (TTL) signal synchronized with the piston pump 
flow wave form triggered the scanner to acquire multiple 
time phases throughout the cycle. The procedure was 
similar to the standard clinical situation in which the 
ECG signal from the subject is used to trigger the scan-
ner for data acqusition. Using echo view sharing (adja-
cent time phases shared some of the acquired k-space 
lines), the temporal resolution was further improved in 
the segmented sequences [30 ms for sequence (a), 30–  45  
ms for sequence (b), and 50–65 ms for sequence (c)]. 
The time corresponding to each phase was the time of 
acquisition of the central line of the segment, since that 
line contained the most useful velocity information of the 
segment. The number of time phases during the 1 s cycle 
was 31 for sequence (a), 22–31 for sequence (b), and 
15–20 for sequence (c). The scanning duration was 3.2 
min for sequence (a), 28 s for sequence (b), and 16 s for 
sequence (c). 
Clinical Measurements 
To evaluate the clinical potential of segmented 
k-space PVM in quantifying blood flow, preliminary 
measurements were performed in two human subjects 
(subject No. 1: male, 70 years old, ascending aortic an-
eurysm; subject No. 2: male, 60 years old, ischemic heart 
disease). Velocity data were acquired with a slice posi-
tioned in the ascending aorta of each subject, at the level 
of the pulmonary artery bifurcation. Two sequences were 
used: (i) the conventional nonsegmented gradient echo; 
and (ii) the segmented TGE with nine lines per segment. 
ECG gating was used to acquire multiple time phases 
throughout the cardiac cycle. The sequence with five 
lines per segment used in the in vitro measurements was 
not tested in the in vivo part, because of its long duration 
(�25 s; more difficult to be performed within a breath 
hold). The ST was 5 mm for both subjects. The scan 
percentages were 75% and 56% for sequences (i) and 
(ii), respectively. The FOV was 263X350 mm2 for sub-
ject No. 1 (rectangular FOV factor of 75%), and 225 
X300 mm2 for subject No. 2 (rectangular FOV factor of 
75%). Combination of the scan percentage with the rect-
angular FOV factor resulted in acquired numbers of 144 
and 108 ky lines for sequence (i) and (ii), respectively. 
The velocity encoding value was 250 cm/s, and the rest 
of the imaging parameters were as in the in vitro part. 
The scan durations for the first sequence were 2.4 and 
2.1 min for subject Nos. 1 and 2, respectively. The sec-
ond sequence was performed within a breath hold (12 
and 11 s for subject Nos. 1 and 2, respectively). For 
subject No. 1, the numbers of time phases acquired were 
31 for the nonsegmented sequence and 19 for the nine-
line segmented sequence. For subject No. 2, these num-
bers were 25 and 15, respectively. 
Data Analysis 
Each PVM acquisition produced a magnitude and a 
phase image (or a series of magnitude and phase images 
during the cycle under pulsatile flow and in the clinical 
cases). All images were transferred to a work station 
(Ultra-10, SUN Microsystems, Inc., Palo Alto, CA). A  
computer program was used to convert the phase values 
of the phase images to velocity values (cm/s), based on 
Eq. (1). Then, the images were visualized using TRANS-
FORM (Version 3.4, Research Systems, Inc., Boulder, 
CO). The tube (in vitro) or the aortic (in vivo) cross 
section was clearly visualized and selected, and the fluid 
velocity was integrated over the tube/aortic cross-
sectional area to find the flow rate (ml/s). For the pulsa-
tile flow in vitro data and for the clinical flow data, 
integration of the flow curve over the cycle provided the 
flow volume (ml/cycle). 
Regression analysis, nonparametric statistical tests 
15(sign test), and Bland–Altman analysis1 were per-
formed to compare the PVM-measured flow values with 
the true flow values (in vitro) and the flow data from the 
segmented techniques with the flow data from the non-
segmented technique (in vitro and in vivo). The MINITAB 
software (Version 13, Minitab, Inc., State College, PA) 
was used for the statistical analysis. A p value<0.05 
demonstrated a significant difference. 
FIGURE 3. Magnitude „a… and phase „b… images acquired 
using the nonsegmented PVM sequence. Magnitude „c… and 
phase „d… images using the segmented phase velocity map-
ping „PVM… sequence with nine lines per segment. The 
phase images contain †encoded according to Eq. „1…‡ the 
velocity information. 
RESULTS 
Figure 3 shows the magnitude and phase images from 
nonsegmented and nine-line segmented PVM acquisi-
tions in the in vitro case. Both images from the nonseg-
mented [Figs. 3(a) and 3(b)] and the segmented [Figs. 
3(c) and 3(d)] sequences were of sufficient quality for 
analysis and flow quantification. 
Figure 4 shows the measured velocity profiles in the 
case of laminar (Re=580), and non-laminar (Re=5250) 
steady flow for the nonsegmented acquisition and the 
segmented with nine lines of k-space per segment. The 
velocity was normalized with respect to the cross-
sectional average velocity. The velocity profiles are very 
similar in the nonsegmented and the segmented cases for 
FIGURE 4. Normalized velocity profiles as measured using 
the nonsegmented „slow… sequence and the segmented „ul-
trafast… sequence with nine k-space lines per segment. Nor-
malization was performed by dividing the local velocity val-
ues with the average cross-sectional velocity. „a… Laminar 
flow; „b… nonlaminar flow. 
TABLE 2. Regression analysis and sign test results for the steady flow data. 
Y (ml/s) X (ml/s) Regression equation R2 SEa (ml/s) Sign test p value 
Segb-5 True Y=1.04 X – 0.61 0.990 6.2 0.33 
Seg-9 True Y=1.05 X – 0.77 0.989 6.5 0.89 
Seg-5 Non-Segc Y=1.01 X – 0.44 0.998 3.1 0.33 
Seg-9 Non-Seg Y=1.02 X – 0.63 0.998 3.0 0.49 
aSE: standard error.  
bSeg: segmented k-space sequence.  
cNon-Seg: Nonsegmented k-space sequence.  
both flow regimes. In laminar flow, the profile is para-
bolic, whereas in nonlaminar flow, the profile is flatter. 
The ratio of the cross-sectional average velocity to the 
maximum measured velocity was found to be approxi-
mately 0.55 for Re=580 and 0.80 for Re=5250. The 
velocity gradient approaching the wall is greater in non-
laminar flow than in laminar flow. 
The known accuracy of the nonsegmented 
4–sequence 6,8,12,21 was confirmed in this study (Y =1.03 
X – 0.04, R2=0.988, standard error=6.7 ml/s; Y: mea-
sured flow rate, X: true flow rate). Close agreement be-
tween the measured flow rate from the two segmented 
sequences and the true flow (from the rotameters), as  
well as between the flow rate from the two segmented 
(ultrafast) sequences and the flow rate from the nonseg-
mented (slow) sequence was found with regression 
analysis (Table 2). The agreement was also confirmed by 
sign tests which produced p values much greater than 
0.05 in all cases. 
The accuracy of the flow rate measurements under 
nonlaminar flow conditions was found to be comparable 
to that of the laminar flow. The mean errors [(measured-
true)/true] for laminar flow were 1.6%, 1.6%, and 0.1% 
for the nonsegmented, five-line segmented, and nine-line 
segmented sequences, respectively; for the nonlaminar 
case, the errors were 5.1%, 3.6%, and 4.5%, respectively. 
Sign tests confirmed the high accuracy of the measured 
FIGURE 5. Measured flow wave forms under pulsatile flow 
conditions. „a… True flow volumeÄ20 mlÕcycle; measured 
flow volumeÄ17.9, 20.8, and 20.2 mlÕcycle for the nonseg-
mented, the five-line segmented and the nine-line segmented 
sequences, respectively. „b… True flow volume Ä 70 mlÕcycle; 
measured flow volumeÄ71.7, 76.0, and 75.0 mlÕcycle for the 
nonsegmented, the five-line segmented and the nine-line 
segmented sequences, respectively. 
flow rates showing comparable p values (�0.05) for both 
the laminar and nonlaminar flow cases. 
Figure 5 shows the measured flow wave forms for 
true flow volumes of 20 and 70 ml/cycle in the pulsatile 
flow studies. The measured flow curves for the different 
sequences are very similar both qualitatively and quan-
titatively. Figure 6 shows the comparison between the 
PVM-measured flow volumes with all three sequences 
(the nonsegmented and the two segmented) and the true 
flow volume known via the flow probe. The mean errors 
were 3.3%, 0.1%, and 0.5% for the nonsegmented, five-
line segmented, and nine-line segmented sequences, re-
spectively. Table 3 shows the regression analysis results 
between the three sequences and the flow probe (true) 
values as well as between the two segmented (fast) se-
quences and the nonsegmented (slow) one. As in the 
steady flow case, the results show a very good agreement 
between the measured and the true flow rate values for 
all sequences, and a very good agreement between the 
segmented and the nonsegmented sequences. These find-
FIGURE 6. Comparison between the PVM-measured and the 
true flow volumes under pulsatile flow conditions for all se-
quences used „Non-Seg: nonsegmented acquisition; Seg-5: 
segmented acquisition with five k-space lines per segment; 
and Seg-9: segmented acquisition with nine k-space lines 
per segment…. 
TABLE 3. Regression analysis and sign test results for the pulsatile flow data. 
SEa 
(ml/cycle) (ml/cycle) Regression equation R2 (ml/cycle) Sign test p value 
Y X 
Segb-5 True Y=1.08 X – 1.65 0.983 3.7 0.84 
Seg-9 True Y=1.12 X – 2.52 0.971 5.1 0.84 
Seg-5 Non-Segc Y=1.02 X+1.21 0.954 6.1 0.13 
Seg-9 Non-Seg Y=1.07 X+0.10 0.958 6.1 0.17 
aSE: standard error.  
bSeg: Segmetned k-space sequence.  
cNon-Seg: Nonsegmetned k-space sequence.  
ings were confirmed by sign tests (Table 3), in which all 
p values are greater than 0.05. In addition, Fig. 7 shows 
the Bland–Altman analysis plot for the comparison be-
tween the measured flow volumes with the nine-line seg-
mented sequence and the true flow volumes. The mean 
and the standard deviation are low (approximately 0.3 
and 2.9 ml/cycle, respectively), and the data points are 
within the ‘‘:2 standard deviations’’ lines. Similar analy-
sis was performed to compare the flow volumes from the 
other sequences with the true flow volumes, and the 
results were identical to the ones presented for the nine-
line segmented sequence. 
Under both steady and pulsatile flow conditions, slice 
thickness and field of view did not seem to affect the 
accuracy of the results. Sign tests showed no significant 
differences (p�0.05) between the two STs (3 vs 5 mm) 
and the different FOVs. 
The aortic flow measurements in the two human sub-
jects showed a close agreement between the nonseg-
mented and the nine-line segmented sequences. The flow 
wave forms were almost identical (Fig. 8). Integration of 
the flow curves over the entire cardiac cycle showed 
agreement (difference =3%) in the calculated flow vol-
umes between the nonsegmented sequence and the nine-
FIGURE 7. Bland–Altman analysis plot comparing the mea-
sured and true flow volumes for the nine-line segmented 
sequence. 
line segmented sequence (subject No. 1, nonsegmented: 
88.1 ml/beat, segmented: 86.1 ml/beat; subject No. 2, 
nonsegmented: 54.6 ml/beat, segmented: 56.4 ml/beat). 
DISCUSSION 
Magnetic resonance phase velocity mapping is a reli-
able velocimetric and flow quantification technique. It 
has been clinically used to measure the flow rate and 
analyze the flow patterns in the heart and vessels such as 
the entire aorta, the carotid arteries, the renal arteries, 
cerebral and peripheral vessels, and small vessels such as 
the coronary arteries. The accuracy and reliability of 
PVM has been shown through a number of in vitro and 
in vivo studies in the past. Nevertheless, conventional 
nonsegmented PVM is relatively slow. It takes 3–5 min 
for a single measurement. Fast techniques are necessary 
to make PVM more practical clinically. This study at-
tempted to evaluate two segmented PVM acquisition 
schemes, one with five k-space lines per segment and 
one with nine lines per segment, and compare the flow 
FIGURE 8. Measured flow wave forms in the ascending aorta 
„level of pulmonary artery bifurcation… of a patient with an 
ascending aortic aneurysm using the nonsegmented se-
quence and the nine-line segmented sequence „Non-Seg: 
nonsegmented acquisition; Seg-9: segmented acquisition 
with nine k-space lines per segment…. 
results to those acquired with the nonsegmented se-
quence as well as with true flow values. PVM measure-
ments under steady and pulsatile flow conditions showed 
that both segmented sequences provided equally accurate 
and reliable results. Increasing the number of k-space 
lines to nine did not show any negative effect on the 
measured flow. 
Image quality was very good for all sequences used 
(Fig. 3) and for all flow conditions facilitating image 
analysis and processing. Under laminar flow conditions, 
the flow profiles were parabolic and smooth [Fig. 4(a)]. 
The centerline velocity was almost twice as large as the 
average cross-sectional velocity. Under nonlaminar flow 
conditions, the profiles were flatter and the maximum 
velocity was much less than twice the cross-sectional 
average velocity [Fig. 4(b)]. The velocity gradient to-
wards the wall was greater in nonlaminar flow than in 
laminar flow. This agreement of the measured velocity 
profiles with what is theoretically and empirically ex-
pected (parabolic profiles for laminar flow, flat-like pro-
files for nonlaminar flow) reflects the velocimetric reli-
ability of the MR PVM technique. Although the in-plane 
spatial resolution was adequate to obtain the details of 
the velocity profile, an even higher resolution would bet-
ter resolve the velocity gradient immediately adjacent to 
the tube wall. This would be important to calculate wall 
shear stress. It should be noted that, technically, it was 
possible to increase spatial resolution by further decreas-
ing the voxel size. However, the effects of reducing 
voxel size on the signal-to-noise ratio and thus image 
quality need to be thoroughly investigated by taking into 
account that there is always a distance between optimal 
in vitro resolution and optimal in vivo resolution. In 
addition, improving the resolution means lengthening the 
acquisition, which is undesired clinically. This limitation 
at the wall did not affect the quantification of flow rate, 
because of the lower velocity magnitudes near the wall 
and the small contribution of those pixels to the overall 
flow rate. 
Of interest is the high accuracy (errors�5%) of the 
flow rate results under nonlaminar flow conditions. Tra-
ditionally, MR imaging has shown limitations in measur-
ing the velocity in regions with turbulence, because of 
voxel signal loss due to velocity fluctuations. Signal loss 
automatically means loss of the phase (velocity) infor-
mation. The technological advancement in MR hardware 
has led to improved magnetic-field gradient performance, 
which in combination with decreased echo times (the 
time between tissue excitation and signal readout) can 
reduce the effects of turbulence on the voxel signal qual-
ity, thus allowing velocity measurements under disturbed 
flow conditions. This study used very small TEs (as low 
as 2.3 ms), because of the ability to operate the very 
strong magnetic-field gradients very fast. As a result, 
PVM acquisition provided clear images in which the 
signal was not reduced. This led to accurate velocity 
information, which, in turn, resulted in accurate flow rate 
quantification. 
It should be emphasized, however, that the results of 
this study do not show that turbulent flow is universally 
quantifiable by PVM. There are many fluid mechanics 
and technical factors involved that need investigation to 
draw safe conclusions on this matter. This study merely 
showed that under the studied range of Re (400–10,500), 
flow can be measured very accurately by ultrafast PVM 
sequences. Further investigations are necessary, under 
larger Re to show the relationship between decreasing 
TE and the ability to measure turbulent flow with PVM. 
The pulsatile flow results (flow volumes) showed 
similar levels of accuracy (errors<5%) as the steady 
flow results. The measured flow curves were very similar 
in all PVM sequences used (Fig. 5). A similar agreement 
was observed in the two in vivo cases examined. It 
should be noted that, in segmented PVM with n lines per 
segment (in which n is an odd number), the most useful 
information is contained in the central line, (n+1)/2, of 
the segment, because this is the closest line of the seg-
ment to the center of k-space. Therefore, the time corre-
sponding to any phase acquired during the cycle was 
adjusted to be the time of acquisition of the central 
k-space line of the segment. Without such an adjustment, 
a temporal shift of the flow curves would take place, as 
previously observed.28 This shift would increase with the 
number of lines per segment. Combination of this tem-
poral adjustment with retrospective ECG gating is nec-
essary clinically to avoid loss of information in the very 
beginning and the very end of the cycle. 
The close agreement of the calculated flow rates and 
flow volumes with the true flow values, as well as the 
agreement of the velocity profiles, flow rates, flow vol-
umes, and flow wave forms between the sequences, sug-
gest that accurate flow quantification is possible using 
ultrafast segmented PVM. The high in vitro accuracy of 
the faster nine-line sequence, in combination with its 
good temporal resolution (� 10 phases per cycle) and 
shorter duration (<20 s) compared to the five-line se-
quence, makes it preferable, considering the difficulty 
some patients have with longer breath holds. This is 
further supported by the preliminary clinical agreement 
found between the nonsegmented and the nine-line seg-
mented flow results in the two subjects examined in this 
study. A larger clinical study will provide more informa-
tion about the clinical feasibility, advantages, and prob-
lems of segmented PVM techniques. 
The in vitro part of this study evaluated two seg-
mented PVM sequences using straight rigid tubes under 
a variety of flow conditions and imaging parameters. 
Flow conditions (range, pulsatility) and tube size par-
tially simulated what is observed clinically, but no other 
physiologic factors, such as wall compliance, wall mo-
tion, presence of stenosis, tube curvature, branching, etc., 
were studied. The aim of this study was to focus on the 
sequences and evaluate them under relatively simple 
flow environments without involving other factors which 
would complicate the situation. Nevertheless, further 
evaluation of these sequences under more physiological 
environments and conditions, and using all three spatial 
velocity components, is necessary in order to further 
increase their reliability and broaden their clinical appli-
cability. 
Increasing the number of k-space lines per segment 
above nine will certainly shorten the acquisition even 
more, but at the expense of temporal resolution. There-
fore, the number of lines should be increased only after 
assuring acquisition of an adequate number of phases per 
cycle in order to prevent loss of valuable information, 
particularly at peak systole. In addition, it is recom-
mended that, before clinically implementing a sequence, 
data from in vitro or in vivo evaluation studies be avail-
able to assure reliability. 
CONCLUSIONS 
Steady and pulsatile flow experiments in straight rigid 
tubes showed that k-space segmented PVM provides ac-
curate, ultrafast velocity measurements and flow quanti-
fication. The technique quantified laminar and nonlami-
nar flow up to a Reynolds number of 10,500 with 
reliability. Increasing the number of k-space lines per 
segment to nine did not show any negative effects on the 
ability of PVM to measure flow with high accuracy. 
Preliminary clinical findings agreed with the experimen-
tal findings. As interest in obtaining detailed quantitative 
information about blood flow noninvasively is continu-
ously increasing, fast protocols are in demand. Ultra-fast 
segmented k-space MR phase velocity mapping shows 
promise to clinically satisfy this need. 
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NOMENCLATURE 
MR magnetic resonance 
PVM phase velocity mapping 
EPI echo planar imaging 
TGE turbo gradient echo 
TE echo time 
TR repetition time 
ST slice thickness 
FOV field of view 
VENC velocity encoding limit value 
Re Reynolds number 
SE standard error 
FISP fast imaging with steady-state precession 
TTL transistor–transistor logic 
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